India needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr Bhawna Sirohi said. A member of the new Lancet Oncology Commission on precision cancer, Sirohi flagged high testing and drug costs and urged their integration into public healthcare schemes.
RSS News
Economic times
0 thoughts on “India needs five-year policy to make precision cancer care afforable, says expert”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- 13th driest monsoon in the country: Punjab received 41% less rainfall, Rajasthan 21% deficit; Monsoon to withdraw from the country by October 10
- India-UAE oil pipeline to be built in the Arabian Sea to Gujarat-Maharashtra
- What time is the ODI World Cup 2027 schedule announced today, will India and Pakistan be in a group?
- N. Raghuraman's column: What fathers once used to do spontaneously, schools are now doing scientifically
- IND vs WI: How much money did Shubman Gill get as a prize for a tumultuous innings of 223 runs?
